NASDAQ:HQY HealthEquity (HQY) Stock Price, News & Analysis $78.07 +0.68 (+0.88%) (As of 02/8/2024 ET) Add Compare Share Share Today's Range$77.45▼$78.8250-Day Range$62.44▼$78.0752-Week Range$48.86▼$78.84Volume443,466 shsAverage Volume674,139 shsMarket Capitalization$6.70 billionP/E Ratio229.62Dividend YieldN/APrice Target$83.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get HealthEquity alerts: Email Address HealthEquity MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside6.6% Upside$83.25 Price TargetShort InterestHealthy3.37% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.81Based on 7 Articles This WeekInsider TradingSelling Shares$3.18 M Sold Last QuarterProj. Earnings Growth40.54%From $1.48 to $2.08 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.39 out of 5 starsMedical Sector299th out of 911 stocksBusiness Services, Not Elsewhere Classified Industry41st out of 85 stocks 2.5 Analyst's Opinion Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $83.25, HealthEquity has a forecasted upside of 6.6% from its current price of $78.07.Amount of Analyst CoverageHealthEquity has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.37% of the outstanding shares of HealthEquity have been sold short.Short Interest Ratio / Days to CoverHealthEquity has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in HealthEquity has recently decreased by 8.25%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldHealthEquity does not currently pay a dividend.Dividend GrowthHealthEquity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HQY. Previous Next 3.2 News and Social Media Coverage News SentimentHealthEquity has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for HealthEquity this week, compared to 4 articles on an average week.Search InterestOnly 6 people have searched for HQY on MarketBeat in the last 30 days. This is a decrease of -45% compared to the previous 30 days.MarketBeat Follows3 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,179,892.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of HealthEquity is held by insiders.Percentage Held by Institutions98.46% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for HealthEquity are expected to grow by 40.54% in the coming year, from $1.48 to $2.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of HealthEquity is 229.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 125.97.Price to Earnings Ratio vs. SectorThe P/E ratio of HealthEquity is 229.62, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 95.12.Price to Earnings Growth RatioHealthEquity has a PEG Ratio of 1.29. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHealthEquity has a P/B Ratio of 3.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About HealthEquity Stock (NASDAQ:HQY)HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.Read More HQY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQY Stock News HeadlinesFebruary 4, 2024 | americanbankingnews.comAnalyzing HealthEquity (NASDAQ:HQY) & Patient Portal Technologies (OTCMKTS:PPRG)February 2, 2024 | americanbankingnews.comQ3 2025 Earnings Estimate for HealthEquity, Inc. Issued By Zacks Research (NASDAQ:HQY)February 8, 2024 | Legacy Research (Ad)LIVE DEMO: Elon Musk’s AI hits 65 MPHI just taped a live demonstration of Elon Musk’s AI in action. Elon already created an “army of millionaires” with Tesla. Looks like he’ll do it again with his AI because unlike ChatGPT, Elon’s AI works in the REAL world.February 2, 2024 | americanbankingnews.comComparing HealthEquity (NASDAQ:HQY) & Top KingWin (NASDAQ:TCJH)February 1, 2024 | finance.yahoo.comIs HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?February 1, 2024 | americanbankingnews.comHealthEquity, Inc. (NASDAQ:HQY) Forecasted to Post Q2 2025 Earnings of $0.45 Per ShareJanuary 24, 2024 | finance.yahoo.comHealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?January 17, 2024 | finance.yahoo.comELV or HQY: Which Is the Better Value Stock Right Now?February 8, 2024 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.January 12, 2024 | finance.yahoo.comInsider Sell: EVP, GC & Corporate Secretary Delano Ladd Sells Shares of HealthEquity Inc (HQY)January 12, 2024 | finance.yahoo.comHealthEquity Recognized by Glassdoor as a Top U.S. Workplace for 2024January 8, 2024 | msn.comHealthEquity (HQY) Upgraded to Buy: Here's What You Should KnowJanuary 8, 2024 | markets.businessinsider.comHealthEquity Announces Year-End HSA Sales Outlook; Presentation at J.P. Morgan Healthcare Conference; Investor DayJanuary 8, 2024 | finance.yahoo.comHealthEquity Announces Year-End HSA Sales Outlook; Presentation at J.P. Morgan Healthcare Conference; Investor DayJanuary 4, 2024 | finance.yahoo.comWhy Is HealthEquity (HQY) Down 2.4% Since Last Earnings Report?January 3, 2024 | finance.yahoo.comAn Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 42% UndervaluedDecember 28, 2023 | sg.finance.yahoo.comHealthEquity, Inc. (HQY) stock price, news, quote & history – Yahoo FinanceDecember 28, 2023 | msn.comDoes HealthEquity (HQY) Have the Potential to Rally 31.37% as Wall Street Analysts Expect?December 26, 2023 | msn.com5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024December 22, 2023 | finance.yahoo.comFormer Director Ian Sacks Sells 45,000 Shares of HealthEquity Inc (HQY)December 22, 2023 | finance.yahoo.comHealthEquity (HQY) Performed Strongly in Q3December 20, 2023 | finance.yahoo.com3 Reasons to Add HealthEquity (HQY) Stock to Your PortfolioDecember 16, 2023 | markets.businessinsider.comBuy Rating on Healthequity (HQY): Undervalued Stock Poised for Growth Amid Market VolatilityDecember 15, 2023 | finance.yahoo.comInsider Sell Alert: EVP, Chief Technology Officer Elimelech Rosner Sells Shares of HealthEquity ...December 14, 2023 | benzinga.comInsider Transaction: Elimelech Rosner Sells $141K Worth Of HealthEquity SharesDecember 14, 2023 | msn.comHealthEquity EVP, CTO sells stock worth $0.14MDecember 13, 2023 | markets.businessinsider.comBuy Rating for Healthequity (HQY) Backed by Strong Financials and Strategic AcquisitionsSee More Headlines Receive HQY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/05/2023Today2/08/2024Next Earnings (Estimated)3/19/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:HQY CUSIPN/A CIK1428336 Webwww.healthequity.com Phone(801) 727-1000Fax801-727-1005Employees3,208Year FoundedN/APrice Target and Rating Average Stock Price Target$83.25 High Stock Price Target$95.00 Low Stock Price Target$72.00 Potential Upside/Downside+6.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$0.34 Trailing P/E Ratio229.62 Forward P/E Ratio52.75 P/E Growth1.29Net Income$-26,140,000.00 Net Margins3.00% Pretax Margin4.67% Return on Equity5.89% Return on Assets3.72% Debt Debt-to-Equity Ratio0.44 Current Ratio4.93 Quick Ratio4.93 Sales & Book Value Annual Sales$861.75 million Price / Sales7.77 Cash Flow$2.75 per share Price / Cash Flow28.37 Book Value$22.40 per share Price / Book3.49Miscellaneous Outstanding Shares85,800,000Free Float83,484,000Market Cap$6.70 billion OptionableOptionable Beta0.55 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Jon Kessler (Age 56)President, CEO & Director Comp: $1.55MDr. Stephen D. Neeleman (Age 56)Founder & Vice Chairman Comp: $770.67kMr. Elimelech Rosner (Age 67)Executive VP & CTO Comp: $1.74MMr. James M. Lucania (Age 45)CFO & Executive VP Ms. Angelique Christine Hill (Age 55)Executive Vice President of Operations Mr. Richard PutnamVice President of Investor RelationsMr. Delano Ladd (Age 43)Executive VP, General Counsel & Secretary Comp: $319.48kMr. Steve LindsayExecutive Vice President of Sales & Relationship ManagementMr. Brad BennionSenior Vice President of Corporate DevelopmentMs. Tia PadiaExecutive VP & Chief Marketing OfficerMore ExecutivesKey CompetitorsThe Ensign GroupNASDAQ:ENSGInspire Medical SystemsNYSE:INSPIntra-Cellular TherapiesNASDAQ:ITCIExelixisNASDAQ:EXELCDK GlobalNASDAQ:CDKView All CompetitorsInsiders & InstitutionsGreat Lakes Advisors LLCBought 113,047 shares on 2/8/2024Ownership: 0.218%Vanguard Personalized Indexing Management LLCBought 631 shares on 2/8/2024Ownership: 0.010%KLR Investment Advisors LLCBought 241 shares on 2/8/2024Ownership: 0.007%Beacon Pointe Advisors LLCSold 263 shares on 2/8/2024Ownership: 0.005%Janney Montgomery Scott LLCBought 140 shares on 2/8/2024Ownership: 0.004%View All Insider TransactionsView All Institutional Transactions HQY Stock Analysis - Frequently Asked Questions Should I buy or sell HealthEquity stock right now? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares. View HQY analyst ratings or view top-rated stocks. What is HealthEquity's stock price target for 2024? 8 equities research analysts have issued 12-month price targets for HealthEquity's stock. Their HQY share price targets range from $72.00 to $95.00. On average, they expect the company's stock price to reach $83.25 in the next year. This suggests a possible upside of 6.6% from the stock's current price. View analysts price targets for HQY or view top-rated stocks among Wall Street analysts. How have HQY shares performed in 2024? HealthEquity's stock was trading at $66.30 at the start of the year. Since then, HQY shares have increased by 17.8% and is now trading at $78.07. View the best growth stocks for 2024 here. Are investors shorting HealthEquity? HealthEquity saw a decrease in short interest during the month of January. As of January 15th, there was short interest totaling 2,890,000 shares, a decrease of 8.3% from the December 31st total of 3,150,000 shares. Based on an average trading volume of 778,400 shares, the short-interest ratio is currently 3.7 days. View HealthEquity's Short Interest. When is HealthEquity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024. View our HQY earnings forecast. How were HealthEquity's earnings last quarter? HealthEquity, Inc. (NASDAQ:HQY) posted its quarterly earnings results on Tuesday, December, 5th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.08. The business earned $249.22 million during the quarter, compared to the consensus estimate of $243.63 million. HealthEquity had a trailing twelve-month return on equity of 5.89% and a net margin of 3.00%. What ETFs hold HealthEquity's stock? ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), SPDR S&P Health Care Services ETF (XHS), Global X FinTech Thematic ETF (FINX), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), Nuveen Small Cap Select ETF (NSCS), Putnam Sustainable Future ETF (PFUT) and iShares U.S. Healthcare Providers ETF (IHF). What guidance has HealthEquity issued on next quarter's earnings? HealthEquity updated its FY 2025 earnings guidance on Monday, December, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion. What is Jon Kessler's approval rating as HealthEquity's CEO? 359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend. What other stocks do shareholders of HealthEquity own? Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP). Who are HealthEquity's major shareholders? HealthEquity's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Mackenzie Financial Corp (2.11%), Dimensional Fund Advisors LP (1.64%), Allspring Global Investments Holdings LLC (1.41%), Charles Schwab Investment Management Inc. (1.17%), Geneva Capital Management LLC (1.01%) and DAVENPORT & Co LLC (0.59%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten. View institutional ownership trends. How do I buy shares of HealthEquity? Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HQY) was last updated on 2/8/2024 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthEquity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.